- Home
- ACN vs MRK Comparison
ACN vs MRK Comparison
Compare ACN & MRK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ACN
- MRK
- Stock Information
- Founded
- ACN 1989
- MRK 2000
- Country
- ACN Ireland
- MRK United States
- Employees
- ACN N/A
- MRK N/A
- Industry
- ACN Business Services
- MRK Biotechnology: Pharmaceutical Preparations
- Sector
- ACN Consumer Discretionary
- MRK Health Care
- Exchange
- ACN Nasdaq
- MRK Nasdaq
- Market Cap
- ACN 226.8B
- MRK 260.8B
- IPO Year
- ACN N/A
- MRK N/A
- Fundamental
- Price
- ACN $352.47
- MRK $97.93
- Analyst Decision
- ACN Buy
- MRK Buy
- Analyst Count
- ACN 20
- MRK 15
- Target Price
- ACN $386.35
- MRK $125.36
- AVG Volume (30 Days)
- ACN 2.8M
- MRK 9.8M
- Earning Date
- ACN 03-20-2025
- MRK 02-04-2025
- Dividend Yield
- ACN 1.68%
- MRK 3.31%
- EPS Growth
- ACN 10.54
- MRK 165.47
- EPS
- ACN 11.93
- MRK 4.78
- Revenue
- ACN $66,361,706,000.00
- MRK $63,174,000,000.00
- Revenue This Year
- ACN $7.02
- MRK $7.50
- Revenue Next Year
- ACN $6.73
- MRK $5.14
- P/E Ratio
- ACN $29.56
- MRK $20.49
- Revenue Growth
- ACN 2.75
- MRK 6.51
- 52 Week Low
- ACN $278.69
- MRK $94.48
- 52 Week High
- ACN $387.51
- MRK $134.63
- Technical
- Relative Strength Index (RSI)
- ACN 47.42
- MRK 42.35
- Support Level
- ACN $347.00
- MRK $98.05
- Resistance Level
- ACN $355.20
- MRK $100.90
- Average True Range (ATR)
- ACN 6.68
- MRK 1.75
- MACD
- ACN -0.29
- MRK 0.04
- Stochastic Oscillator
- ACN 42.12
- MRK 0.00
About ACN Accenture plc (Ireland)
Accenture is a leading global IT-services firm that provides consulting, strategy, and technology and operational services. These services run the gamut from aiding enterprises with digital transformation to procurement services to software system integration. The company provides its IT offerings to a variety of sectors, including communications, media and technology, financial services, health and public services, consumer products, and resources. Accenture employs just under 500,000 people throughout 200 cities in 51 countries.
About MRK Merck & Company Inc. (new)
Merck makes pharmaceutical products to treat several conditions in a number of therapeutic areas, including cardiometabolic disease, cancer, and infections. Within cancer, the firm's immuno-oncology platform is growing as a major contributor to overall sales. The company also has a substantial vaccine business, with treatments to prevent pediatric diseases as well as human papillomavirus, or HPV. Additionally, Merck sells animal health-related drugs. From a geographical perspective, just under half of the company's sales are generated in the United States.